Temozolomide For Brain Cancer: A Practical Patient Guide
Comprehensive guide to temozolomide (Temodal®) for treating glioblastoma and malignant gliomas in adults and children.
Temozolomide, also known by the brand name Temodal®, is an oral chemotherapy medication specifically used to treat certain types of brain tumors in adults and children. It is prescribed for newly diagnosed glioblastoma multiforme alongside radiotherapy and for malignant gliomas that have not responded to standard treatments.
| Type of medicine | An anti-cancer medicine |
|---|---|
| Used for | Certain types of brain cancer |
| Also called | Temodal® |
| Available as | Capsules |
About temozolomide
Temozolomide belongs to a group of medicines called antineoplastics, which work by interfering with the DNA of cancer cells, preventing them from dividing and multiplying. This alkylating agent is unique because it can cross the blood-brain barrier, allowing it to reach tumors in the brain effectively.
It is primarily indicated for adults newly diagnosed with glioblastoma multiforme, where it is initially combined with radiotherapy, followed by temozolomide alone. For malignant gliomas, it serves as a second-line treatment when tumors recur or fail to respond to prior therapies. Large clinical trials have demonstrated that temozolomide with radiotherapy improves survival rates compared to radiotherapy alone in high-grade gliomas.
The medication is prescribed by oncologists specializing in brain tumors. Dosing is calculated based on body surface area (height and weight) and tailored to the patient’s response and tolerance.
How do you take temozolomide?
Temozolomide is administered orally in capsule form, typically once daily at the same time each day. Swallow capsules whole with a full glass of water, preferably on an empty stomach (1 hour before or 2 hours after meals) to optimize absorption.
Treatment follows a cyclical schedule to balance efficacy and minimize toxicity:
- Concomitant phase (with radiotherapy): Daily dosing for 6-7 weeks, even on weekends/non-radiotherapy days. Dose is lower, around 75 mg/m².
- Rest period: 4 weeks off all treatment after radiotherapy ends for recovery.
- Maintenance (monotherapy) phase: Higher dose (150-200 mg/m²) for 5 days every 28 days, up to 6-12 cycles or longer if tolerated and effective. Blood tests on day 22 or 28 of each cycle monitor counts.
For recurrent malignant gliomas, it’s used similarly in cycles. Total duration depends on tumor response via MRI scans, side effect tolerance, and up to 12-24 cycles. Always follow your doctor’s exact schedule; a treatment diary helps track doses.
Key facts about temozolomide
- Temozolomide improves average survival in high-grade gliomas when combined with radiotherapy.
- It is effective against tumors with methylated MGMT gene promoter, enhancing DNA repair inhibition.
- Capsules come in 5 mg, 20 mg, 100 mg, 140 mg, 180 mg, and 250 mg strengths.
- Store at room temperature, away from moisture and heat.
- Not for use in pregnancy; effective contraception required during and 6 months after treatment.
Getting the most from your treatment
To maximize benefits:
- Take exactly as prescribed; do not adjust doses without consulting your doctor.
- If you miss a dose, take it as soon as remembered unless close to the next dose—never double up.
- Avoid alcohol, as it may worsen nausea.
- Maintain good oral hygiene to prevent infections from low white cells.
- Report any new symptoms promptly for dose adjustments or supportive care.
Blood tests are routine before each cycle to check full blood count, liver, and kidney function. Treatment may be delayed if counts are low.
Side-effects of temozolomide
Like all chemotherapy, temozolomide causes side effects by affecting healthy cells, especially those dividing rapidly (bone marrow, gut, hair follicles). Most are manageable; severity varies.
Common side effects
- Nausea and vomiting: Affects up to 50%; start anti-emetics (e.g., ondansetron) preventively. Take temozolomide at bedtime if needed.
- Low blood counts (myelosuppression): Nadir 21-28 days post-dose. Causes fatigue, infections (low WBC), bleeding (low platelets), anemia. Monitor closely.
- Fatigue: Common; rest and light exercise help.
- Loss of appetite, constipation: Use stool softeners, high-fiber diet.
- Headache, hair loss (alopecia): Usually mild, reversible.
Serious side effects (seek immediate help)
- Fever/infection signs: >38°C fever, chills, sore throat.
- Bleeding/bruising: Nosebleeds, blood in urine/stool.
- Severe allergic reactions: Rash, swelling, breathing difficulty.
- Liver problems: Jaundice, dark urine.
- Pneumocystis pneumonia (PCP): Rare; prophylaxis (co-trimoxazole) often given during concomitant phase.
Long-term: Increased risk of secondary cancers (e.g., leukemia), infertility. Discuss fertility preservation pre-treatment.
How to cope with side effects
| Side effect | What to do |
|---|---|
| Nausea | Anti-nausea meds, small bland meals, ginger tea. |
| Fatigue | Pace activities, short naps, balanced diet. |
| Low blood counts | Avoid crowds/raw foods, hand hygiene, dental check pre-treatment. |
| Hair loss | Wigs/scarves, gentle shampoo. |
| Constipation | Hydrate, laxatives as advised. |
Your oncology team provides supportive medications and advice.
Pregnancy and breastfeeding
Temozolomide is harmful to unborn babies (teratogenic). Use effective contraception during treatment and 6 months after for both genders. Breastfeeding must stop during and 1 week after therapy. Inform your doctor if pregnant/planning.
Other precautions
- Driving/operating machinery: May cause drowsiness; avoid until effects known.
- Interactions: Inform about all meds, including over-the-counter. Avoid live vaccines.
- COVID-19: Low immunity increases risk; follow guidelines.
Frequently asked questions
Can I drink alcohol while taking temozolomide?
Avoid alcohol, as it can increase nausea and liver strain.
What if I vomit after taking a dose?
Do not repeat; contact your doctor. They may advise skipping or anti-emetics.
How long does treatment last?
Typically 6 weeks with RT + 6-12 maintenance cycles, or until progression/intolerance.
Will my hair grow back?
Yes, usually 3-6 months post-treatment.
Is temozolomide suitable for children?
Yes, for recurrent malignant gliomas.
References
- Temozolomide for brain cancer (Temodal) — Patient.info. 2023. https://patient.info/medicine/temozolomide-for-brain-cancer-temodal
- Temozolomide (TMZ) — The Brain Tumour Charity. 2024-01-15. https://www.thebraintumourcharity.org/brain-tumour-diagnosis-treatment/treating-brain-tumours/adult-treatments/chemotherapy/temozolomide/
- Temodar (temozolomide) – Brain Tumor — UCLA Health. 2023-05-10. https://www.uclahealth.org/cancer/cancer-services/brain-tumor/patient-resources/common-medication-information/temodar
- Temozolomide (Temodal) — Cancer Research UK. 2024-02-20. https://www.cancerresearchuk.org/about-cancer/treatment/drugs/temozolomide
- Temozolomide (oral route) — Mayo Clinic. 2024-08-01. https://www.mayoclinic.org/drugs-supplements/temozolomide-oral-route/description/drg-20066228
- Temozolomide — Macmillan Cancer Support. 2023-11-12. https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/temozolomide
Similar Articles
Read full bio of medha deb
